Skip to main content

Table 7 TNF-α gene polymorphism and femoral head necrosis in cured SARS patients.

From: Roles of TNF-α gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study

SNP site

Femoral head necrosis (%)

Non-femoral head necrosis (%)

OR* (95%C.I.)

P

-1031

    

   Genotype

    

TT

6(40)

28(80)

  

CT

8(53.7)

7(20)

5.33(1.39–20.45)

0.01

CC

1(6.7)

0

5.67(2.74–11.71)$

0.04

   Allele

    

T

66.67

90.00

  

C

33.33

10.00

  

-863

    

   Genotype

    

CC

9(56.3)

33(89.2)

  

AC

7(43.7)

4(10.8)

6.42(1.53–26.88)

0.01

   Allele

    

C

78.12

94.59

  

A

21.88

5.41

  

-857

    

   Genotype

    

CC

12(75)

26(70.3)

  

CT

4(25)

11(29.7)

0.78(0.21–2.99)

0.73

   Allele

    

C

87.50

85.14

  

T

12.50

14.86

  

-572

    

   Genotype

    

AA

16(100)

36(97.3)

  

AC

0

1(2.7)

1.44(1.21–1.73)

0.70

   Allele

    

A

100

98.7

  

C

0

1.3

  

-308

    

   Genotype

    

GG

14(87.5)

32(86.5)

  

AG

2(12.5)

4(10.8)

1.14(0.19–6.98)

0.89

AA

0

1(2.7)

1.44(1.19–1.74)

0.70

   Allele

    

G

93.37

91.89

  

A

6.25

8.11

  

-238

    

   Genotype

    

GG

13(81.3)

33(89.2)

  

AG

3(18.7)

4(10.8)

1.90(0.37–9.71)

0.35

   Allele

    

G

90.62

94.59

  

A

9.38

5.41

  
  1. Note: *:OR was calculated using non-femoral head necrosis as control.
  2. $:OR replaced by femoral head necrosis;
  3. ‡: OR estimated by non-femoral head necrosis;